Literature DB >> 16285255

Human serum for culture of articular chondrocytes.

Tommi Tallheden1, Josefine van der Lee, Camilla Brantsing, Jan-Eric Månsson, Eva Sjögren-Jansson, Anders Lindahl.   

Abstract

In the field of cell and tissue engineering, culture expansion of human cells in monolayer plays an important part. Traditionally, cell cultures have been supplemented with serum to support attachment and proliferation, but serum is a potential source of foreign protein contamination and viral protein transmission. In this study, we evaluated the use of human serum for experimental human articular chondrocyte expansion and to develop a method for preparation of large volumes of high-quality human serum from healthy blood donors. Human autologous serum contained high levels of epidermal-derived growth factor and platelet-derived growth factor-AB and supported proliferation up to 7 times higher than FCS in primary chondrocyte cultures. By letting the coagulation take place in a commercially available transfusion bag overnight, up to 250 ml of growth factor-rich human serum could be obtained from one donor. The allogenic human serum supported high proliferation rate without losing expression of cartilage-specific genes. The expanded chondrocytes were able to redifferentiate and form cartilage matrix in comparable amounts to autologous serums. In conclusion, the transfusion bags allow preparation of large volumes of growth factor-rich human serum with the capacity to support in vitro cell expansion. The data further indicate that by controlling the coagulation process there are possibilities of optimizing the release of growth factors for other emerging cell therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16285255     DOI: 10.3727/000000005783982909

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  12 in total

1.  Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage.

Authors:  Thomas H Alexander; August B Sage; Albert C Chen; Barbara L Schumacher; Elliot Shelton; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

2.  Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source.

Authors:  Cecilia Boreström; Stina Simonsson; Lars Enochson; Narmin Bigdeli; Camilla Brantsing; Catharina Ellerström; Johan Hyllner; Anders Lindahl
Journal:  Stem Cells Transl Med       Date:  2014-03-06       Impact factor: 6.940

3.  Bone marrow mesenchymal stem cells in a hyaluronan scaffold for treatment of an osteochondral defect in a rabbit model.

Authors:  S Løken; R B Jakobsen; A Arøen; S Heir; A Shahdadfar; J E Brinchmann; L Engebretsen; F P Reinholt
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-07-01       Impact factor: 4.342

4.  Evaluation of Polycaprolactone-Associated Human Nasal Chondrocytes as a Therapeutic Agent for Cartilage Repair.

Authors:  Do Hyun Kim; Mi Hyun Lim; Se Hwan Hwang; Sung Won Kim; Jung Ho Jeun; Sun Hwa Park; WeonSun Lee; Sang Hi Park; Mi Yeon Kwon
Journal:  Tissue Eng Regen Med       Date:  2019-08-19       Impact factor: 4.169

5.  Rapid Chondrocyte Isolation for Tissue Engineering Applications: The Effect of Enzyme Concentration and Temporal Exposure on the Matrix Forming Capacity of Nasal Derived Chondrocytes.

Authors:  Srujana Vedicherla; Conor Timothy Buckley
Journal:  Biomed Res Int       Date:  2017-02-28       Impact factor: 3.411

6.  GDF5 induces TBX3 in a concentration dependent manner - on a gold nanoparticle gradient.

Authors:  L Andreasson; H Evenbratt; S Simonsson
Journal:  Heliyon       Date:  2020-06-10

7.  Standardisation of basal medium for reproducible culture of human annulus fibrosus and nucleus pulposus cells.

Authors:  Ann-Kathrin Schubert; Jeske J Smink; Matthias Pumberger; Michael Putzier; Michael Sittinger; Jochen Ringe
Journal:  J Orthop Surg Res       Date:  2018-08-22       Impact factor: 2.359

8.  Tissue Specific Differentiation of Human Chondrocytes Depends on Cell Microenvironment and Serum Selection.

Authors:  Annemarie Ecke; Anne-Helen Lutter; Jenny Scholka; Anna Hansch; Roland Becker; Ursula Anderer
Journal:  Cells       Date:  2019-08-19       Impact factor: 6.600

9.  Biosafety evaluation of culture-expanded human chondrocytes with growth factor cocktail: a preclinical study.

Authors:  Maimonah-Eissa Al-Masawa; Wan Safwani Wan Kamarul Zaman; Kien-Hui Chua
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

Review 10.  Feasibility of Human Platelet Lysate as an Alternative to Foetal Bovine Serum for In Vitro Expansion of Chondrocytes.

Authors:  Ling Ling Liau; Muhammad Najib Fathi Bin Hassan; Yee Loong Tang; Min Hwei Ng; Jia Xian Law
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.